English, Article edition: The Cost to the United Kingdom National Health Service of Managing Erectile Dysfunction: The Impact of Sildenafil and Prescribing Restrictions Edward C.F. Wilson; Emma S. McKeen; Paul A. Scuffham; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/95074
Physical Description
  • article
Language
  • English

Edition details

Title
  • The Cost to the United Kingdom National Health Service of Managing Erectile Dysfunction: The Impact of Sildenafil and Prescribing Restrictions
Author
  • Edward C.F. Wilson
  • Emma S. McKeen
  • Paul A. Scuffham
  • Martin C.J. Brown
  • Kevan Wylie
  • Geoff Hackett
Physical Description
  • article
Notes
  • Objective: To estimate the annual direct cost of managing erectile dysfunction (ED) to the UK National Health Service (NHS) and to examine the impact of the introduction of sildenafil in 1998 and Schedule 11 restrictions in 1999. Design: A prevalence-based cost-of-illness approach was used. The period 1997 to 2000 was covered. The numbers of ED prescriptions, prosthesis implantations and general practitioner (GP) consultations were retrieved retrospectively from UK resource utilisation databases. The number of specialist consultations and psychosexual therapy sessions were estimated from NHS clinic data. National resource unit costs were applied. Main outcomes and results: Between 1997 and 2000 the number of men presenting with ED increased from 79 800 to 257 984. The cost to the NHS increased from Lstg 29.4 million to Lstg 73.8 million (2000 estimates). The cost per patient fell from Lstg 368 to Lstg 286. In 1997, most NHS costs came from psychosexual therapy (30.7%), specialist consultations (20.2%) and intracavernosal injections (26.6%). By 2000, NHS costs came primarily from specialist consultations (32.0%), sildenafil prescriptions (26.2%), psychosexual therapy (13.6%) and GP consultations (12.0%). The annual cost was most sensitive to the number of drug prescriptions and specialist consultations. Conclusions: The increased NHS cost of managing ED was due mainly to a three-fold increase in the number of men presenting to GPs, substantial numbers of whom were then referred for specialist consultations under Schedule 11 restrictions. This naturally resulted in the increased use of all resources including sildenafil. The cost effectiveness of transferring prescribing responsibility in cases of severe distress from specialists to GPs in primary care remains to be determined.
  • Alprostadil, Cost analysis, Drug utilisation, Erectile dysfunction, Erectile dysfunction therapies, Pharmacoeconomics, Resource use, Sildenafil
  • RePEc:wkh:phecon:v:20:y:2002:i:13:p:879-889
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment